findmyKOL
Clinical trialNCT00666328CompletedPhase 3Interventional

Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)

SponsorThe Medicines CompanyEnrollment37HemorrhageHypertension
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study was to determine the efficacy and safety of clevidipine for treating acute hypertension (high blood pressure, defined as systolic blood pressure \>160 mmHg) in patients with intracerebral hemorrhage (i.e., bleeding in the brain; stroke).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • Universitätsklinikum Leipzig

    Liebigstraße 22a, Leipzig, Germany

  • Universitatsklinikum Erlangen

    Erlangen, Germany

  • Universitatsklinikum Heidelberg

    Heidelberg, Germany

United States
  • Washington Hospital Center

    Washington D.C., District of Columbia, United States

  • the Queens Medical Center

    Honolulu, Hawaii, United States

  • the John Hopkins Hospital

    Baltimore, Maryland, United States

  • Maine Medical Center

    Portland, Massachusetts, United States

  • Henry Ford Hospital

    Detroit, Michigan, United States

  • Columbia University Medical Center

    New York, New York, United States

  • Duke University Medical Center

    Durham, North Carolina, United States

  • Guilford Neurologic - Moses H Cone Health System

    Greensboro, North Carolina, United States

  • Cleveland Clinic Hospitals

    Cleveland, Ohio, United States

  • the Ohio State University

    Columbus, Ohio, United States

  • Thomas Jefferson University Stroke Research

    Philadelphia, Pennsylvania, United States

  • Medical University of South Carolina

    Charleston, South Carolina, United States

  • the University Health Science Center at S.A.

    San Antonio, Texas, United States

  • Intermountain Medical Center

    Murray, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Clevidipine →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2008
Primary completion
30 Apr 2010
Completion
30 Apr 2010
Last update posted
29 Aug 2014
Registered enrollment
37
Registry id
NCT00666328
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.